Potential for Raman spectroscopy to provide cancer screening using a peripheral blood sample

Area of Science:

• Biomedical Engineering
• Analytical Chemistry
• Oncology

Background:

• Cancer incidence is rising globally, necessitating advancements in early detection.
• Current UK screening programs target specific cancers, highlighting a need for broader diagnostic tools.
• Early diagnosis of solid tumors via peripheral blood analysis could significantly improve patient outcomes.

Purpose of the Study:

• To investigate the feasibility of using Raman spectroscopy for cancer screening.
• To discriminate between cancer patients and controls using blood-based biochemical fingerprints.
• To develop and assess machine learning classifiers for spectral data analysis.

Main Methods:

• Collected peripheral blood samples from 40 patients (Head and Neck cancer vs. respiratory illness controls).
• Applied Raman spectroscopy to generate biochemical fingerprints of blood samples.
• Utilized Principal Component Analysis/Linear Discriminant Analysis (PCA/LDA) and a genetic evolutionary algorithm for spectral classification.

Main Results:

• The PCA/LDA classifier achieved 65% sensitivity and specificity in distinguishing cancer from respiratory samples.
• A trained evolutionary algorithm classifier demonstrated improved performance with 75% sensitivity and 75% specificity.
• Preliminary data indicates Raman spectroscopy can differentiate between cancer and non-cancer blood samples.

Conclusions:

• Raman spectroscopy is a feasible technique for the preliminary screening and diagnostics of solid tumors through peripheral blood.
• This non-invasive method offers potential for early cancer detection and intervention.
• Further research is required to validate and implement this technique in clinical settings.